Global trends in inappropriate use of antibiotics, 2000-2021: scoping review and prevalence estimates.

BMJ public health Pub Date : 2025-05-27 eCollection Date: 2025-01-01 DOI:10.1136/bmjph-2024-002411
Ranya Mulchandani, Katie Tiseo, Arindam Nandi, Eili Klein, Sumanth Gandra, Ramanan Laxminarayan, Thomas Van Boeckel
{"title":"Global trends in inappropriate use of antibiotics, 2000-2021: scoping review and prevalence estimates.","authors":"Ranya Mulchandani, Katie Tiseo, Arindam Nandi, Eili Klein, Sumanth Gandra, Ramanan Laxminarayan, Thomas Van Boeckel","doi":"10.1136/bmjph-2024-002411","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Inappropriate antibiotic use is a major driver of antimicrobial resistance. However, the scope of literature and its prevalence across world regions remain largely unknown, as do the most common indicators and study designs used. In this study, we summarised the current literature on inappropriate use of antibiotics by world regions. We also provided the first global estimates of the overall amount of antibiotics that are potentially used inappropriately each year.</p><p><strong>Methods: </strong>We considered both patient and provider-mediated inappropriate antibiotic use. We reviewed 412 studies published between 2000 and 2021 and used beta regression and marginal contrasts to compare prevalence of inappropriate use by study design, indicator, world region, and national income level. Country-level sales of antibiotics from 2022 were combined with inappropriate antibiotic use estimates derived from two study designs (clinical audits and patient interviews) and one indicator (lack of indication) to estimate the amount of antibiotics inappropriately used globally.</p><p><strong>Results: </strong>Clinical audits (50.1%, 208/412) and 'non-prescription' use (37.1%, 153/412) were the most common study design and indicator, respectively, used to estimate inappropriate antibiotic use. Inappropriate antibiotic use prevalence was ~6% higher in low-income and middle-income than in high-income countries. However, this difference disappeared after accounting for a proxy of access to care: physicians per capita. Globally, based on clinical audits, patient interviews and lack of indication, the estimated proportion of inappropriate antibiotic use was 29.5%, 36.5% and 30.8%, respectively, with an average of ~30% (~13 000 000 kg) the equivalent of the annual antibiotic consumption in China.</p><p><strong>Conclusions: </strong>Inappropriate antibiotic use is highly prevalent across all countries regardless of national income level, with a third of global antibiotic consumption potentially due to unnecessary prescription ('lack of indication'). Antibiotic stewardship efforts and defining internationally standardised indicators are needed to track progress in reducing the occurrence of inappropriate antibiotic use where necessary, as well as identifying gaps in access to care.</p>","PeriodicalId":101362,"journal":{"name":"BMJ public health","volume":"3 1","pages":"e002411"},"PeriodicalIF":0.0000,"publicationDate":"2025-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12121568/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMJ public health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/bmjph-2024-002411","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Inappropriate antibiotic use is a major driver of antimicrobial resistance. However, the scope of literature and its prevalence across world regions remain largely unknown, as do the most common indicators and study designs used. In this study, we summarised the current literature on inappropriate use of antibiotics by world regions. We also provided the first global estimates of the overall amount of antibiotics that are potentially used inappropriately each year.

Methods: We considered both patient and provider-mediated inappropriate antibiotic use. We reviewed 412 studies published between 2000 and 2021 and used beta regression and marginal contrasts to compare prevalence of inappropriate use by study design, indicator, world region, and national income level. Country-level sales of antibiotics from 2022 were combined with inappropriate antibiotic use estimates derived from two study designs (clinical audits and patient interviews) and one indicator (lack of indication) to estimate the amount of antibiotics inappropriately used globally.

Results: Clinical audits (50.1%, 208/412) and 'non-prescription' use (37.1%, 153/412) were the most common study design and indicator, respectively, used to estimate inappropriate antibiotic use. Inappropriate antibiotic use prevalence was ~6% higher in low-income and middle-income than in high-income countries. However, this difference disappeared after accounting for a proxy of access to care: physicians per capita. Globally, based on clinical audits, patient interviews and lack of indication, the estimated proportion of inappropriate antibiotic use was 29.5%, 36.5% and 30.8%, respectively, with an average of ~30% (~13 000 000 kg) the equivalent of the annual antibiotic consumption in China.

Conclusions: Inappropriate antibiotic use is highly prevalent across all countries regardless of national income level, with a third of global antibiotic consumption potentially due to unnecessary prescription ('lack of indication'). Antibiotic stewardship efforts and defining internationally standardised indicators are needed to track progress in reducing the occurrence of inappropriate antibiotic use where necessary, as well as identifying gaps in access to care.

2000-2021年抗生素不当使用的全球趋势:范围审查和流行率估计。
不适当的抗生素使用是抗菌素耐药性的主要驱动因素。然而,文献的范围及其在世界各地的流行程度在很大程度上仍然未知,最常见的指标和使用的研究设计也是如此。在本研究中,我们总结了目前世界各地关于抗生素不当使用的文献。我们还首次提供了每年可能被不当使用的抗生素总量的全球估计。方法:我们考虑了患者和提供者介导的不适当抗生素使用。我们回顾了2000年至2021年间发表的412项研究,并使用β回归和边际对比来比较研究设计、指标、世界地区和国家收入水平的不适当使用的患病率。从2022年起的国家一级抗生素销售情况,结合两项研究设计(临床审计和患者访谈)和一项指标(缺乏指征)得出的不适当抗生素使用估计数,以估计全球不适当使用的抗生素数量。结果:临床审计(50.1%,208/412)和“非处方”使用(37.1%,153/412)分别是最常见的研究设计和指标,用于估计不适当的抗生素使用。低收入和中等收入国家的不适当抗生素使用流行率比高收入国家高6%。然而,在考虑了人均医生人数这一可获得医疗服务的指标后,这种差异就消失了。在全球范围内,根据临床审计、患者访谈和缺乏指征,估计不适当使用抗生素的比例分别为29.5%、36.5%和30.8%,平均约为中国年抗生素消费量的30%(约1300万公斤)。结论:不适当的抗生素使用在所有国家都非常普遍,无论国民收入水平如何,全球抗生素消费的三分之一可能是由于不必要的处方(“缺乏指征”)。需要开展抗生素管理工作并确定国际标准化指标,以便在必要时跟踪减少抗生素不当使用的进展情况,并确定获得护理方面的差距。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信